ArticleArthroscopy, sports medicine, and rehabilitation2022
Open Anterior Capsular Reconstruction With a Dermal Allograft Is a Viable Nonarthroplasty Salvage Procedure for Irreparable Subscapularis Tears at a Minimum 2-Year Follow-up.
Article in Arthroscopy, sports medicine, and rehabilitation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Anterior Capsular Reconstruction With Dermal Allograft Augmentation for Multidirectional Shoulder Instability.Arthroscopy techniques · 2026Article
- Chronic recurrent shoulder instability treated with a hemiarthroplasty, Glenojet allograft glenoid reconstruction, and anterior capsular reconstruction: a case report.JSES reviews, reports, and techniques · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To elucidate the clinical outcomes of patients who underwent anterior capsular reconstruction (ACR) with dermal allograft for irreparable subscapularis tears in native shoulders at a minimum of 2-year follow-up. Methods: This study included patients who underwent ACR by a single surgeon between March 2015 and September 2018. Clinical and intraoperative findings were recorded. Patient-reported outcomes were evaluated pre- and postoperatively, including American Shoulder and Elbow Surgeons, Single Assessment Numeric Evaluation, General Health Short-Form 12 Physical Component Summary and patient satisfaction (on a 1-10 scale, with 10 = best). Failure was defined as revision subscapularis surgery or conversion to reverse total shoulder arthroplasty. Results: Seven patients who underwent ACR at a mean age of 53 ± 7.3 years at the time of surgery were included. Median time from injury to surgery was 13.8 months (range 13.8-32.0 months). Two patients had concomitant superior capsular reconstruction. One patient progressed to a reverse total shoulder arthroplasty at 6.8 months. Minimum 2-year follow-up was obtained in the remaining 6 of 6 (100%) patients, with a mean follow-up of 3.4 years (range 2.0-6.2). There was significant improvement in the Quick Disabilities of the Arm, Shoulder and Hand score (preoperative: 32.7, postoperative: 9.5, Conclusions: This small cohort of patients had a significant improvement in Quick Disabilities of the Arm, Shoulder and Hand score, high patient satisfaction, and relatively low conversion rate to reverse total shoulder arthroplasty. These clinical outcomes demonstrate that ACR with a dermal allograft may be a viable salvage operation for irreparable subscapularis tears in the short-term. Level of Evidence: Level IV, therapeutic case series.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.